Chest MRI: Indications, Contraindications, and Alternatives
Chest MRI should be reserved for specific clinical scenarios where it provides unique diagnostic information not obtainable by other modalities, particularly for oncologic staging, vascular assessment when CT is contraindicated, and evaluation of chest wall/mediastinal invasion.
Primary Indications
Oncologic Applications
- Anterior mediastinal masses to exclude non-neoplastic conditions 1
- Pancoast tumors planned for radical surgery (strongly recommended) 1
- Suspected chest wall, vertebral, diaphragm, or major vessel invasion by non-small cell lung cancer or malignant pleural mesothelioma 1
- Lung masses in pneumoconiosis patients to differentiate progressive massive fibrosis from lung cancer 1
The evidence shows a clear shift in utilization patterns, with oncologic indications increasing from 10.9% to 36.8% of chest MRI examinations over recent years, while confirmed malignant diagnoses increased from 3.2% to 10.2% 2. This reflects MRI's superior soft tissue contrast for tumor staging.
Vascular Indications
- Acute aortic syndrome when CT angiography is contraindicated 3, 4
- Pulmonary embolism in pregnancy using non-contrast or minimal-dose low-risk contrast media 1
- Known aortic disease follow-up (considered method of choice) 3
Cardiac Applications
- Acute chest pain evaluation in clinically stable patients when comprehensive cardiovascular assessment is needed, including ischemia, inflammation, and function 3
- Myocardial infarction assessment when CT is contraindicated 4
Absolute Contraindications
Cardiac Implantable Electronic Devices (CIEDs)
Other Metallic Implants
- Certain metallic implants or shrapnel (device-specific assessment required) 6
Relative Contraindications
CIED-Related
- Leads implanted <6 weeks before planned MRI 5
- Epicardial leads 5
- Abandoned transvenous leads 5
- Scan region overlapping with CIED location (cardiac, thorax, or brachial plexus) 5
Patient-Related
- Severe claustrophobia 6
- Severe obesity (scanner-dependent) 6
- Inability to cooperate or remain still (motion artifact decreased from 5.3% to 3.3% with technical improvements, but remains a limitation) 2
Renal Impairment
- eGFR <30 mL/min/1.73 m² when using group I linear gadolinium-based contrast agents (GBCAs) - these agents are contraindicated 5
- Risk of nephrogenic systemic fibrosis (NSF) is 1-7% with group I agents in severe renal impairment 5
Contrast Agent Selection
When GBCAs are required, use macrocyclic or newer linear agents (group II or III) rather than older linear agents (group I) 5. This is a strong recommendation based on high-quality evidence, as nearly all NSF cases have been reported with group I agents, while few if any have been associated with group II or III agents.
Preferred Alternatives
First-Line Modalities
CT with contrast for:
Ultrasound or CT before MRI for cardiac, abdominal, and pelvic abnormalities 6
Either CT or MRI can be used for lower back pain 6
When MRI is Superior
- Soft tissue conditions (MRI better than CT) 6
- Tumors, congenital abnormalities, vascular structures 6
- Cervical or thoracic spine 6
- Patients requiring radiation avoidance (pediatric, pregnant, frequent follow-up imaging) 7
Key Clinical Pitfalls
Off-hours examinations show significantly more technical quality limitations - schedule electively when possible 2
Vascular pathology detection has declined from 17.3% to 2.1% in recent years, suggesting CT angiography has largely replaced MRI for vascular indications except when contraindicated 2
Patient screening for metallic implants must be thorough - arrange chest radiography if none available since last device intervention 5
For patients with implantable pulmonary artery pressure monitors (CardioMEMS), perform scans at 1.5T in monitored settings, using only body coil (surface coils interfere with device function) 5